⚕ Rx (Prescription Required)Oncology & Critical CareTargeted Therapies & Kinase Inhibitors

Erlotinib

Active pharmaceutical substance formulated in Jan Aushadhi generic products for Oncology & Critical Care treatment.

🧴 Clinical Application

Take orally once daily on an EMPTY STOMACH: at least 1 hour before or 2 hours after food with a full glass of water. Food dramatically increases bioavailability by nearly 100%, leading to severe toxicities. Avoid smoking (cigarette smoke induces CYP1A2, reducing erlotinib plasma levels by >50-60%).

⚠️ Side Effects

Common: Acneiform pustular skin rash (face, chest, back in >75% of patients; rash presence correlates with tumor response), diarrhea, anorexia, fatigue, paronychia, dry skin. Rare/Severe: Interstitial lung disease (ILD / pneumonitis), corneal perforation/ulceration, and gastrointestinal perforation.

🛡️ Safety Warnings

Must be taken on an empty stomach. Interrupt or discontinue immediately if acute onset of unexplained dyspnea, cough, and fever occurs (interstitial lung disease can be fatal). Concomitant use of PPIs (omeprazole, pantoprazole) decreases erlotinib absorption by >50%; space antacids or avoid PPIs. Dose must be increased in active cigarette smokers.

Jan Aushadhi Products containing Erlotinib

Found 1 generic formulation(s) containing this active ingredient.

⚕ Rx OnlyTargeted Therapies & Kinase Inhibitors

Erlotinib Tablets 150 mg

Tablets
10's Bottle

Erlotinib Tablets (150mg) is an oral first-generation epidermal growth factor receptor (EGFR / HER1) tyrosine kinase inhibitor on the WHO Model List of Essential Medicines. It reversibly competes with ATP for binding to the intracellular kinase domain of EGFR harboring activating mutations (exon 19 in-frame deletions or exon 21 L858R point mutations), blocking autophosphorylation and downstream pro-survival RAS/RAF/MAPK signaling. Indicated for first-line and maintenance therapy of metastatic non-small cell lung cancer (NSCLC) with sensitizing EGFR mutations, and in combination with gemcitabine for locally advanced, unresectable pancreatic cancer.

₹656.25₹2182.4270% saved
Erlotinib

Brand Equivalents & Price Comparison

Compare Jan Aushadhi generic prices against popular commercial brands for Erlotinib.

Generic FormulationPack SizeJan Aushadhi PriceCommercial Brand EquivalentsAvg. Commercial PriceSavings
Erlotinib Tablets 150 mg10's Bottle₹656.25ZYCEVA, ERLOT, ERLOTAD₹2182.4270% Save

Frequently Asked Questions (FAQ)

Get answers to common queries about Erlotinib generics.

How many Jan Aushadhi products contain Erlotinib?＋
This directory currently lists 1 Jan Aushadhi generic product(s) containing Erlotinib as an active pharmaceutical ingredient (API). The count reflects the July 2026 PMBI catalog snapshot.
Does Erlotinib require a prescription at Jan Aushadhi Kendras?＋
Yes. Erlotinib is classified as a prescription-required (Rx) ingredient under applicable Indian drug schedules. You must present a valid prescription from a registered medical practitioner to obtain it at a Jan Aushadhi Kendra.
What is the lowest listed price for Erlotinib at Jan Aushadhi?＋
Based on the July 2026 PMBI catalog, the lowest listed MRP for a Erlotinib formulation is ₹656.25. Individual prices vary by pack size and dosage form. Use the product links above for the exact MRP of each formulation.
Are Jan Aushadhi Erlotinib products clinically equivalent to branded versions?＋
Jan Aushadhi generics contain the same declared active pharmaceutical ingredient (Erlotinib) at the same concentration as branded counterparts and must meet CDSCO quality standards. However, inactive excipients, release mechanisms, and manufacturing processes can differ between manufacturers. Never switch a prescribed medicine without consulting your doctor.
Find a Jan Aushadhi Kendra Near You
Search 21,118 listed government pharmacies across India by PIN code. Find Erlotinib products at government prices.
Search Kendras